Copyright
©The Author(s) 2023.
World J Clin Cases. Feb 6, 2023; 11(4): 738-755
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.738
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.738
Figure 1 Pan-cancer analysis of CD93.
A: Differential expression of CD93 between normal and tumor tissues in pan-cancer based on the TIMER2.0; B: Associations between CD93 expression and overall survival in pan-cancer. The P values are labeled as aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Li Z, Zhang XJ, Sun CY, Fei H, Li ZF, Zhao DB. CD93 serves as a potential biomarker of gastric cancer and correlates with the tumor microenvironment. World J Clin Cases 2023; 11(4): 738-755
- URL: https://www.wjgnet.com/2307-8960/full/v11/i4/738.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i4.738